Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

A Phase 1 Trial of AP30663, a KCa2 Channel Inhibitor in Development for Conversion of Atrial Fibrillation.

Christina Yfanti,Birgitte Vestbjerg, Juliette van't Westende,Nils Edvardsson,Laia Meseguer Monfort,Morten Salling Olesen,Bo Hjorth Bentzen,Morten Grunnet,Boukje C. Eveleens Maarse,Jonas Goldin Diness,Michiel J. B. Kemme,Ulrik Sorensen,Matthijs Moerland,Michiel J. van Esdonk,Erica S. Klaassen,Pim Gal,Anders G. Holst

British Journal of Clinical Pharmacology（2023）

Cited 0|Views34
Key words
atrial fibrillation,Ca2+ activated K+ (K(Ca)2) channel,QT interval
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined